Abstract
Background
Primary small cell carcinoma of the endometrium is very rare, and there have been no reports on KIT and PDGFRA in endometrial small cell carcinoma.
Case report
An 87-year-old woman was admitted to our hospital because of genital bleeding. Endometrial cytology and biopsy revealed small cell carcinoma. Scrutiny of the body showed stage III endometrial carcinoma with metastases. An immunohistochemical study of the biopsy specimens revealed positive reactions for synaptophysin, CD56, KIT, and PDGFRA, and negative reactions for cytokeratins, neuron-specific enolase, and chromogranin. A molecular genetic analysis using PCR-direct sequencing identified no mutations of KIT (exons 9, 11, 13, and 17) and PDGFRA (exons 12 and 18) genes. The patient received chemotherapy and radiation, but showed a downhill course, and died of carcinomatosis 6 months after the initial presentation.
Conclusion
The present case is the first reported case of primary small cell carcinoma of the endometrium with an examination of KIT and PDGFRA expressions and KIT and PDFGRA gene mutations.
Similar content being viewed by others
References
Huntsman DG, Clements PB, Gilks CB, Scully RE (1994) Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am J Surg Pathol 18:364–375
van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ (1995) Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 14:21–29
Varras M, Akrivis Ch, Demou A, Hadjopoulos S, Antoniou N (2002) Primary small-cell carcinoma of the endometrium: clinicopathologic study of a case and review of the literature. Eur J Gynecol Oncol 23:577–581
Albores-Saavedra J, Martinez-Benitez B, Luevano E (2008) Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27:333–339
LaPoint RJ, Bourne PA, Wang HL, Xu H (2007) Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. Appl Immunohistochem Mol Morphol 15:401–406
Lopes-Martin A, Ballenstin C, Garcia-Carbonero R, Castano A, Lopez-Rios F, Lopes-Encuentra A, Sanchez-Cespedes M, Castellano D, Bartolomes A, Cortes Funes H, Paz-Ares L (2007) Prognostic value of KIT expression in small cell lung carcinoma. Lung Cancer 56:405–413
Micke P, Basral M, Faldum A, Bittinger F, Ronnstrand L, Blaukat A, Beeh KM, Oesch F, Fischer B, Buhl R, Hengstler JG (2003) Characterization of c-kit expression in small cell lung carcinoma: prognostic and therapeutic implications. Clin Cancer Res 9:188–194
Camps C, Sirera R, Bremnes RM, Garde J, Safont MJ, Blasco A, Berrocal A, Sanchez JJ, Calabuig C, Marrorell M (2006) Analysis of c-kit expression in small cell lung carcinoma: prevalence and prognostic implications. Lung Cancer 52:343–347
Rossi G, Cavazza A, Marchioni A, Miggaldi M, Bavierli M, Fracciolongo N, Petruzzelli S, Longo L, Tamberi S, Crino L (2003) KIT expression in small cell carcinoma of the lung: effects of chemotherapy. Mod Pathol 16:1041–1047
Naeem M, Dahiya M, Clark JI, Creech SD, Alkin S (2002) Analysis of c-kit protein expression in small-cell lung carcinoma and its implications for prognosis. Hum Pathol 33:1182–1187
Mojica WD, Saxena R, Starostik P, Cheney RT (2005) CD117+ small cell lung cancer lacks the asp 816 val point mutation in exon 17. Histopathology 47:517–522
Boldrini L, Ursino S, Gisfredi S, Faviana P, Donati V, Camcci T, Lucchi M, Mussi A, Basolo F, Pingitore R, Fontanini G (2004) Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Clin Cancer Res 15:4101–4108
Burger H, Den Bakker MA, Stoter G, Verweij J, Nooter K (2003) Lack of c-kit exon 11 activating mutations in c-kit/CD117-positive SCLC tumor specimens. Eur J Cancer 39:793–799
Sihto H, Sarlomo-Rikara M, Tynnienen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H (2005) KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 23:49–57
Hirota S, Isozaki K (2006) Pathology of gastrointestinal stromal tumor. Pathol Int 56:1–9
Losota J, Miettinen M (2006) KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diang Pathol 23:91–101
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumor: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shimomura Y, Kitamura Y (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumor. Science 279:577–580
Hirota S, Ohashi A, Nishida T, Isozaki K, Kinoshita K, Shinomura Y, Kitamura Y (2003) Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumor. Gastroenterology 125:660–667
Miettinen M, Lasota J (2005) KIT (CD117): a review on expression in normal and neoplastic tissue, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13:205–220
Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y (2002) Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 52:740–746
Terada T, Kawaguchi M (2005) Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med 271:271–275
Terada T (2009) Gastrointestinal stromal tumor of the uterus: a case report with genetic analyses of c-kit and PDGFRA genes. Int J Gynecol Oncol 28:29–34
Terada T (2009) Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. Med Oncol 26:233–237
Terada T (2008) Primary multiple extragastrointestinal stromal tumors of the omentum with different mutations of c-kit gene. Would J Gastroenterol 14:7256–7259
Terada T (2009) Mediastinal seminoma with multiple KIT gene mutations. Pathology 41:695–697
Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH (2004) Expression of imatinib mesylate-targeted kinase in endometrial carcinoma. Gynecol Oncol 95:32–36
Scobie JV, Acs G, Bandera CA, Blank SV, Wheeler JE, Pasha TL, Salscheider M, Zhang PJ (2003) C-kit immunoreactivity in endometrial adenocarcinoma and its clinicopathologic significance. Int J Gynecol Pathol 22:149–155
Conflict of interest statement
The author declares no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terada, T. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes. Arch Gynecol Obstet 282, 413–416 (2010). https://doi.org/10.1007/s00404-009-1324-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-009-1324-5